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To predict development of acute kidney injury and its
outcome we retrospectively studied children having cardiac
surgery. Acute kidney injury (AKI) was defined using the
serum creatinine criteria of the pediatric Risk Injury Failure
Loss End-Stage (pRIFLE) kidney disease definition. We tested
whether a small rise (less than 50%) in creatinine on post-
operative days 1 or 2 could predict a greater than 50%
increase in serum creatinine within 48h in 390 children.
AKI occurred in 36% of patients, mostly in the first 4 post-
operative days. Using logistic regression, significant
independent risk factors for AKI were bypass time, longer
vasopressor use, and a tendency for younger age. Using Cox
regression, AKI was independently associated with longer
intensive care unit stay and duration of ventilation. Patients
whose serum creatinine did not increase on post-operative
days 1 or 2 were unlikely to develop AKI (negative predictive
values of 87 and 98%, respectively). Percentage serum
creatinine rise on post-operative day 1 predicted AKI within
48h (area under the curve¼ 0.65). Our study shows that AKI
after pediatric heart surgery is common and is a risk factor for
poorer outcome. Small post-operative increases in serum
creatinine may assist in the early prediction of AKI.
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Acute kidney injury (AKI) is a risk factor for mortality,
longer length of stay and hospital costs in critically ill
children and adults1–4. Cardiac surgery incurs risk for AKI
through hypotension, inflammation and nephrotoxic medi-
cation use.5 Previous pediatric heart surgery research has
focused mostly on the incidence and risk factors of severe
AKI or on dialysis requirement.6–9 Disease patterns and
severity spectrum of AKI after pediatric cardiac surgery are
still unclear. Recent studies of adult cardiac surgery show the
importance of mild post-operative serum creatinine (SCr)
rise as a predictor of outcome.10 With the recent derivation of
an AKI definition, it is possible to provide a detailed
epidemiological description of AKI in children undergoing
cardiac surgery.1,11,12 This population is of particular interest,
as much of current early AKI biomarker research is emerging
from this group of patients. AKI is currently defined as an
acute (48 h) rise in SCr to X50% above baseline.12 This
definition was derived by expert consensus and was validated
in children for AKI description in other pediatric popula-
tions.4 It is not known whether a smaller SCr rise may also be
clinically significant.
Our goals were (1) to describe the incidence and risk factors
of AKI after pediatric cardiac surgery; (2) to determine
whether AKI, defined by the standardized definition or by a
25% post-operative SCr rise, is independently associated with
a longer length of stay and a longer length of mechanical
ventilation; and (3) to calculate the predictive value of early
small SCr rise in the prediction of 50% SCr within 48 h.
RESULTS
Study population
Twelve patients with no SCr data were excluded. Their mean
age, intensive care length of stay, cardiopulmonary bypass
time, gender, and surgical severity score distribution were not
statistically different from those of the remaining sample (not
shown). The remaining sample had 390 patients, mean±s.d.
(median (IQR)) age¼ 2.8±4.7 (0.5 (3.8)) years (36.7% less
than 3 months old), weight¼ 12.7±15.3 kg (6.6 (10.6)),
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baseline estimated glomerular filtration rate¼ 75.3±30.8
(73.7 (49.4)) ml/min/1.73m2. Of them, 222 (56.9%) were
male patients, 337 (86.4%) underwent cardiopulmonary
bypass (111.4±86.1, 104 (77) min, all patients) and 261
(66.9%) underwent aortic cross-clamping (45.3±41.4, 45.5
(73) min, all patients). The Aristotle score was 7.6±2.3 (8
(3)) and 218 (55.9%) had a RACHS-1 surgical severity score
X3. Descriptive data are shown in Table 1.
Acute kidney injury incidence and characterization
The completeness of SCr data was as follows: 99% had daily
SCr forX25% of intensive care unit days, 91% had daily SCr
for X half the days and 41.5% had daily SCr for X90% of
intensive care unit days. Of the 390 patients, 373 (95.6%) had
baseline SCr available; 140 (35.9%) developed AKI by
pediatric Risk, Injury, Failure, Loss, End-Stage Kidney
Disease (SCr criteria, pRIFLESCr) criteria; 80 (20.5%)
Table 1 | Characteristics of all patients and of patients with versus without acute kidney injury (AKI)
Mean±s.d., median (IQR)
Characteristic All (N=390) With AKI (N=140) No AKI (N=250)
Continuous
Age (years) 2.8±4.7, 0.5 (3.8) 1.7±4.1, 0.3 (1.1) 3.4±4.9, 0.7 (4.9)**
Weight (kg) 12.7±15.3, 6.6 (10.6) 9.3±12.7, 5.4 (5.3) 14.7±16.3, 7.8 (12.8)**
Baseline eGFR (ml/min/1.73m2) 75.3±30.8, 73.7 (49.4) 75.6±32.2, 72.5 (49.5) 75.1±30.1, 75.0 (50.4)
Aristotle score 7.6±2.3, 8 (3) 8.2±2.1, 8 (3) 7.3±2.3, 7.5 (3.0)**
CPB time (min) 111.4±86.1, 104 (77) 146.1±107.3, 128 (66) 91.4±63.2, 90 (74)**
X-clamp (min) 45.3±41.4, 45.5 (73) 60.8±40.9, 61 (49) 36.4±39.1, 30 (63)**
Intra-op blood (cc/kg) 35.0±34.8, 27.7 (60.5) 46.2±33.3, 46.3 (45.3) 28.6±34.1, 16.1 (48.6)**
POD1 lowest BP 74.1±17.5, 74.5 (25) 66.5±16.3, 65 (20) 78.3±16.7, 78.5 (25)**
Days ventilated 4.4±6.3, 2 (4) 6.1±6.0, 4 (6) 3.4±6.3, 2 (3)**
Days on pressors 4.2±4.6, 3 (3) 6.2±5.6, 4 (5) 3.0±3.5, 2 (3)**
Days on Abx 4.0±5.7, 2 (2) 5.2±6.3, 2 (5) 3.4±5.3, 2 (2)**
Days in hospital before PICU 3.3±11.3, 0 (2) 3.6±11.0, 0 (2.5) 3.1±11.5, 0 (2)
PICU LOS 7.9±8.8, 5 (6) 10.3±9.0, 7 (8) 6.6±8.4, 4 (4)**
Hospital LOS 20.3±30.4, 12 (14) 22.0±17.2, 15 (18) 19.3±35.7, 10 (13)**
N (%)
Categorical
Male 222 (56.9) 85 (60.7) 137 (54.8)
RACHS-1
1 10 (2.6) 0 10 (4.0)
2 208 (53.3) 72 (51.4) 136 (54.4)
3 122 (31.3) 43 (30.7) 79 (31.6)
4 30 (7.7) 16 (11.4) 14 (5.6)*
5 0 0 0
6 12 (3.1) 5 (3.6) 7 (2.8)
Other 8 (2.1) 4 (2.9) 4 (1.6)
Diagnosis
ASD/VSD 87 (22.3) 33 (23.6) 54 (21.6)
TOF/DORV 60 (15.4) 34 (24.3) 26 (10.4)
TGAb 23 (5.9) 9 (6.4) 14 (5.6)
HLHSb/ 34 (8.7) 18 (12.9) 16 (6.4)
Hypolastic arch
RV–PA conduit 16 (4.1) 3 (2.1) 13 (5.2)
Aortic coarc 18 (4.6) 2 (1.4) 16 (6.4)
Vascular ring 5 (1.3) 1 (0.7) 4 (1.6)
Fontan procedure 25 (6.4) 10 (7.1) 15 (6.0)
Others 122 (31.3) 30 (21.4) 92 (36.8)**
CPB (yes) 337 (86.4) 135 (96.4) 202 (80.8)*
X-clamp (yes) 261 (66.9) 116 (82.9) 145 (58.0)**
Antibiotic use 348 (89.2) 121 (86.4) 227 (90.8)
ECMO 5 (1.3) 3 (2.1) 2 (0.8)
Dialysis 7 (1.8) 6 (4.3) 1 (0.4)*
PD only n= 4 n= 3 n= 1
CRRT only n= 1 n= 1
Combination of modalities n= 2 n= 2
Mortality 4 (1.0) 4 (2.9) 0*
ABx, antibiotics; aortic coarc, aortic coarctation; ASD/VSD, atrial septal defect/ventricular septal defect; CPB, cardiopulmonary bypass; CRRT, continuous renal replacement
therapy; eGFR, estimated glomerular filtration rate; HLHS, hypoplastic left heart syndrome; LOS, length of stay; PD, peritoneal dialysis; PICU, pediatric intensive care unit; POD1
lowest BP, lowest blood pressure on post-operative day 1; RACHS-1, risk adjustment in congenital heart surgery surgical severity score; TGA, transposition of the great arteries;
TOF/DORV, tetralogy of fallot/ double-outlet right ventricle; RV–PA, right ventricle to pulmonary arterty; X-clamp, cross-clamp.
*Po0.05, **Po0.005, comparing AKI versus non-AKI groups.
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developed pRIFLESCr R; 41 (10.5%) developed pRIFLESCr I;
and 19 (4.9%) developed pRIFLESCr F AKI. The AKI
rate was similar from 2003 to 2006 inclusive, ranging from
32 to 39%. AKI rates ranged from 30% in winters to 40% in
summers (P40.05, w2-test comparing the four seasons).
There was little difference in the AKI rate whether AM or
PM SCr was used; of 358 patients with AM and PM SCr,
AKI occurred in 41% using AM SCr values and in 38% using
PM SCr values (P40.05). Of the seven patients requiring
dialysis, five had pRIFLESCr I or F AKI, one had pRIFLESCr R
and one patient did not classify as having AKI. AX25% SCr
rise from baseline occurred in 232 of the 390 (59.5%)
patients.
In 61 of 140 (43.6%) patients with AKI, AKI status was
first attained on post-operative day (POD) 1 and in 57 of 140
(40.7%) on POD 2. Figures 1a and b display the distribution
of post-operative days on which AKI first appeared and the
duration (number of consecutive days) of the first AKI
episode. As shown in Figure 1a, if AKI did not appear by
POD 4, patients were very unlikely to develop AKI later.
Mean±s.d. (median (IQR)) number of days duration of
the initial AKI episode was 2.8±3.0 (2 (2)). As shown in
Figure 1b, 43.6% of the first AKI episodes lasted for 1 day;
22.1% lasted for 2 days and 15.7% lasted longer. Of 101
patients whose initial AKI designation was pRIFLESCr R, 19
(19%) progressed to a worse pRIFLESCr stratum (12 patients
to pRIFLESCr I, 7 to pRIFLESCr F). In the other 39 patients
with AKI, the initial pRIFLESCr stratum achieved was
pRIFLESCr I or F.
A repeat AKI episode was very uncommon. Four patients
had AKI ‘resolution’ for 48 h or more, followed by a repeat
episode. Each of these repeat episodes only lasted 1 day and
did not attain higher than pRIFLESCr R.
Risk factors of AKI
Table 1 describes patients’ characteristics, outcomes, and
univariate analyses comparing patients with and without
AKI. In summary, patients with AKI were younger (median
ages 1.1 vs 4.9 years), had slightly higher mean Aristotle
scores (8.2 vs 7.3), longer mean cardiopulmonary bypass and
cross-clamping times (146.1 vs 91.4 and 60.8 vs 36.4 min,
respectively), received more intraoperative blood (med-
ian¼ 46.3 vs 16.1 cc/kg), and had lower trough systolic
blood pressure on POD 1 (66.5 vs 78.3 mm Hg) (all Po0.005,
shown in Table 1). They received mechanical ventilation and
vasopressors for a longer duration (medians¼ 4 vs 2 days for
both) and had longer intensive care and hospital stays
(medians¼ 7 vs 4 and 15 vs 10 days, respectively) (all
Po0.005). All four deaths occurred in patients who had AKI.
A multiple logistic regression analysis was performed to
evaluate for risk factors of development of AKI. We initially
considered all potential risk factors listed in Table 1,
particularly those with statistical and clinical significance in
univariate analyses. A correlation matrix (displaying the
correlation between all variables that might be entered into a
regression model) of these potential risk factor variables
revealed high collinearity for baseline estimated glomerular
filtration rate (with age), weight (with age), lowest POD 1
systolic blood pressure (with age and days receiving
vasopressors), intraoperative blood per kg (with age and
weight) and days ventilated (with days receiving vasopres-
sors). Moreover, all patients who underwent cross-clamp also
received cardiopulmonary bypass. We therefore included the
six remaining variables, namely, age, gender, cardiopulmon-
ary bypass time, days on vasopressors, days on antibiotics and
Aristotle scores and interaction terms between age and each
of the other variables. In addition, we repeated the analyses
substituting Aristotle score with the presence of RACHS-1
score Xvs o3. In our final model, longer cardiopulmonary
bypass time (Odds Ratio or OR¼ 1.01, 95% CI¼ 1.003–1.01,
P¼ 0.001) and higher number of days of receiving vasopres-
sors (OR¼ 3.68, 95% CI¼ 2.15–6.30, Po0.001) were in-
dependently associated with AKI development. Younger age
trended toward an association with AKI (OR¼ 0.68, 95%
CI¼ 0.45–1.002, P¼ 0.057). The analyses replacing the
Aristotle score for the RACHS-1 score Xversus o3 were
almost identical (not shown).
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Figure 1 | Timing and duration of the first AKI episode.
(a) Post-operative day of first evidence of acute kidney injury,
defined asX50% serum creatinine rise from baseline, on the x
axis. The y axis depicts numbers of patients first attaining acute
kidney injury on the given day. (b) Duration (days) of first acute
kidney injury episode is displayed on the x axis. The y axis depicts
the numbers of patients having a given duration of acute kidney
injury.
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To determine whether, in patients who underwent
cardiopulmonary bypass, cross-clamp time was associated
with AKI, we repeated the analysis in patients who under-
went cardiopulmonary bypass, including all other variables.
Only longer vasopressor duration was strongly associated
with AKI (OR¼ 3.31, 95% CI¼ 2.00–5.47, Po0.001), and
longer cross-clamp time was marginally associated
(OR¼ 1.01, 95% CI¼ 1.00–1.01, P¼ 0.046).
AKI as a risk factor of longer length of stay and length of
ventilation
Table 2 shows unadjusted and adjusted ORs of AKI as a risk
factor for longer intensive care and hospital stays and ventilation
duration. We defined AKI by the traditionalX50% SCr rise and
repeated analyses when defining AKI as aX25% SCr rise from
baseline. In unadjusted analyses, AKI defined both ways was
associated with increased risk for longer intensive care and
hospital stays and for longer ventilation duration (all ORs
ranging from 0.6 to 0.7, shown in Table 2). When adjusting for
age, gender, cardiopulmonary bypass time, baseline estimated
glomerular filtration rate, Aristotle (or RACHS-1) score and the
presence of vasopressors, AKI was independently associated
with a longer intensive care stay and mechanical ventilation
duration (Table 2), whether defined by a 25 or 50% SCr rise.
Longer cardiopulmonary bypass time and younger age were also
independently associated with longer lengths of stay and days of
ventilation in all analyses (not shown).
Prediction of AKI using early small SCr rise
On POD 1, 324 patients had SCr measurement and did not
have AKI defined by the standard X50% SCr rise. Of those,
68 (21%) had a 25 to 50% SCr rise on POD 1 (that is, ‘early’
SCr rise). A 25–50% SCr rise-predicted progression toX50%
SCr within 48 h with good specificity and a negative
predictive value on POD 1 (83 and 85%, respectively) and
POD 2 (78 and 97%, respectively). The presence of any SCr
rise from baseline on POD 1 predicted a further progression
to X50% within 48 h with good sensitivity and a negative
predictive value on POD 1 (78 and 87%, respectively) and
with excellent sensitivity and a negative predictive value on
POD 2 (91 and 98%, respectively). The area under the curve
of percentage rise in SCr to predict future rise to X50%
above baseline in patients without AKI yet was similar on
POD 1 and 2 (0.68 and 0.65, respectively, both ROC curves
shown in Figure 2). Diagnostic characteristics and 95% CIs
are displayed in Table 3.
DISCUSSION
This is the first study describing AKI incidence, severity, risk
factors, and effect on outcome using the recently accepted
pRIFLE definition in children undergoing cardiac surgery.
Thirty-six percent of patients developed AKI, mostly
within 3 days after surgery. Table 4 shows recent studies
describing AKI in similar populations, using different AKI
definitions. The AKI rate in our cohort was similar to that
described in an American pediatric cohort using a similar
definition.13–16 Several past studies used SCr doubling
Table 2 | Association of AKI with PICU, length of hospital stay, and length of mechanical ventilation
Unadjusted hazard ratioa (95% confidence interval) Adjusted hazard ratio (95% confidence interval)
AKI category PICU LOS Hospital LOS Days of ventilation PICU LOS Hospital LOS Days of ventilation
25% SCr rise or worse 0.6 (0.5–0.7)* 0.7 (0.6–0.9)* 0.6 (0.5–0.7)* 0.7 (0.5–0.9)* 0.8 (0.6–1.0) 0.7 (0.6–0.9)*
50% SCr rise or worse 0.6 (0.5–0.7)* 0.7 (0.6–0.8)* 0.6 (0.5–0.7)* 0.7 (0.5–0.9)* 0.9 (0.7–1.1) 0.7 (0.6–0.9)*
AKI: acute kidney injury; LOS, length of hospital stay; PICU, pediatric intensive care unit; SCr, serum creatinine.
aA hazard ratio below zero denotes less likelihood of achieving the event, which is hospital discharge or extubation. Therefore hazard ratioo1 equates to longer length of
stay and longer duration of ventilation.
*Po0.05.
POD 1
1.00
0.75
0.50
0.25
0.00
0.00 0.25 0.50 0.75 1.00
1-specificity
POD 2
0.00 0.25 0.50 0.75
1-specificity
Area under ROC curve = 0.6508
1.00
1.00
0.75
0.50
0.25
0.00
Se
ns
itiv
ity
Area under ROC curve = 0.6830
Se
ns
itiv
ity
Figure 2 |Prediction of AKI using percentage serum creatinine
rise from baseline as a predictor. Receiver operating characteristic
(ROC) curve (sensitivity versus 1-specificity plot) showing percentage
serum creatinine rise from baseline on post-operative day 1 (a)
and post-operative day 2 (b) to predict aX50% SCr rise within 48h.
AKI, acute kidney injury; POD, post-operative day, SCr, serum
creatinine.
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(equivalent to pRIFLESCr I) as the AKI definition, reporting
AKI rates ranging from 6 to 17%,7,17,18 similar to our finding
of 10.5%. One study examined the rate of SCr tripling
(pRIFLESCr F) reported in 1% of their cohort, compared with
4.5% of ours. Using dialysis need as an AKI definition is
subject to bias because of institutional practice, explaining
the wide variation in dialysis after pediatric heart surgery,
ranging from 0 to 17%.6–8,17,18 Our center’s practice is to
initiate dialysis only with severe AKI or with severe diuretic-
unresponsive fluid overload (1.8% of our patients). Unique
to our study was our ability to examine several potential AKI
risk factors because of our two prospectively collected
institutional PICUes and Cardioaccess databases. We re-
moved variables that had a high collinearity with other
variables, which could lead to spurious results in interpreting
significance. Longer cardiopulmonary bypass time (and in
patients receiving cardiopulmonary bypass, longer aortic
cross-clamp time), younger age and longer duration of
vasopressor administration predicted AKI occurrence in
multivariate models. Although no other study has evaluated
risk factors of AKI in such an extensive manner, longer
cardiopulmonary bypass time 6,8,9,16,18 and younger age 7–9
have consistently emerged as risk factors.
If the future of AKI research includes evaluating novel
therapies, it is important to understand AKI disease patterns.
We found that SCr first rises by 50% within the first 3–4 days
after surgery, mirroring findings from a few other stu-
dies.7,13,16 We explicitly showed that AKI episodes rarely last
more than 5 days and that repeat AKI episodes are extremely
uncommon. As our center does not routinely insert
peritoneal dialysis catheters in children undergoing heart
surgery, we provided a ‘natural history’ of post-operative AKI.
AKI, whether defined by a 25 or 50% SCr rise, was
independently associated with longer length of stay and
mechanical ventilation. The finding that even very mild acute
perturbations in renal function have an effect on outcome
has been found in studies of adults undergoing heart surgery
and in noncardiac critically ill children.1,3,10,19,20 In our study,
Table 3 | Diagnostic characteristics of different criteria for small serum creatinine rises to predict AKIa within the following 48h
Sensitivity,
% (95% CI)
Specificity,
% (95% CI)
PPV,
% (95% CI)
NPV,
% (95% CI)
AUC,
% (95% CI)
Post-operative day (POD) 1 (only patients with no AKI on POD 1)
SCrb 25–50% above baseline (yes or no) 37.1 (25.2–50.3) 82.8 (77.7–87.2) 33.8 (22.8–46.3) 84.8 (79.8–88.9) —
Any SCr rise above baseline (yes or no) 77.9 (73.4–82.4) 44.9 (39.5–50.4) 30.6 (25.6–35.6) 86.7 (83.0–90.4) —
POD 1 SCr/baseline  100 (%, continuous)c 0.68 (0.61–0.75)
POD 2 (only patients with no AKI on POD 1 or 2)
SCr 25–50% above baseline (yes or no) 45.5 (16.8–76.6) 78.1 (72.4–83.1) 8.6 (2.9–19.0) 96.9 (93.4–98.9) —
Any SCr rise above baseline (yes or no) 90.5 (86.8–94.2) 40.8 (34.6–47.0) 12.6 (8.4–16.7) 97.9 (96.0–99.7) —
POD 2 SCr/baseline  100 (%, continuous)c 0.65 (0.47–0.84)
AKI, acute kidney injury; AUC, area under the curve; NPV, negative predictive value; PPV, positive; predictive value; SCr, serum creatinine.
aAKI: defined by a X50% rise in SCr from baseline.
bSCr on the day of assessment was expressed as a percentage of baseline SCr (SCr/baseline  100).
cThis continuous variable was treated as a biomarker to predict further rise in SCr to 50% above baseline within 48 h.
Table 4 | Summary of selected studies since 2000 on acute kidney injury (AKI) in children undergoing cardiac surgery
First author Population AKI definition(s) AKI rate
Skippen18 N=101; o16 years old; all CPBa SCr doubling from baseline 11%
Tripling of SCr 1%
Need for dialysis 0
Kist-van Holthe7 N=1075; o17 years old; all CPB SCr doubling if 48 weeks old or 475mmol/l
if o8weeks old
17%
Need for dialysis 2.3%
Pedersen8,9 N=1128; o15.6 years old; all congenital heart
surgeries; 41% RACHS-1 X3
Need for dialysis 11.5%
Chan6 N=182; o3 years old; open heart surgery
excluded early (o72 h) deaths; 25% RACHS-1 X3
SCr 475mmol/l or urine output o1ml/kg/h for at
least 4 h and need for dialysis
17%
Nguyen16 N=106; o18 years old; all CPB; study to
investigate urine aprotinin to diagnose
X50% SCr rise from baseline within 3 post-operative days 30%a
AKI; 48% RACHS-1 X3
Backer17 N=2481; o18 years old; all CPB; study comparing
outcome with versus without aprotinin use;
mean Aristotle score = 7.5
SCr doubling from baseline in first 3 post-operative days 5.5%
Need for dialysis o1%
CPB, cardiopulmonary bypass; RACHS-1, risk adjustment in congenital heart surgery surgical severity score; SCr, serum creatinine.
aThese investigators report AKI (as defined in the table) rates ranging from 28 to 51% in other studies performed at their center in similar cohorts (13–15). Figure 1a). Day of
first AKI episode.
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this effect was independent of several factors, including
vasopressor use, antibiotic use, age, gender, and surgical
severity score. The mechanism of the effect of such small SCr
rises on outcome is unclear. It is not known to what extent
kidney ‘injury’, defined pathologically by renal tubular cell
death, actually occurs in patients with such a small, transient
SCr rise. AKI biomarker studies help to answer this question.
The mechanism of the negative effect of AKI on length of
ventilation might be explained by fluid overload. It would be
of interest in future studies to examine the interaction
between presence of mild, moderate, and severe AKI,
development of fluid retention, and their effect on respira-
tory compromise.
Given the findings in adults of very small SCr rise-
predicting mortality10 and given the current era of identify-
ing early AKI biomarkers, we hypothesized that very small
SCr rises might predict a further AKI-defining 50% SCr rise.
In other words, we used small SCr rise as an ‘early biomarker’
of AKI, similar to the way other new urine protein
biomarkers have been studied.15,21,22 Patients with no SCr
rise from baseline on POD 1 were very unlikely to develop
any AKI in the future (negative predictive value¼ 87%); on
POD 2, patients who still did not have any SCr rise from
baseline were extremely unlikely to develop AKI (negative
predictive value¼ 98%). Percentage SCr rise from baseline on
POD 1 or POD 2 resulted in an area under the curve of
B0.65 for predicting future AKI occurrence. Although this
area under the curve is not very promising alone, one can
imagine that in combination with new AKI biomarkers,
paying close attention to very early rises in SCr might
substantially contribute to our armamentarium in early AKI
prediction.
The limitations of this study have mostly to do with the
retrospective design, wherein problems with data accuracy
must be considered. However, our research findings on AKI
risk factors are in keeping with previous research, and
fortunately, the level of missing data was extremely low. Our
sample size did not allow us to examine all possible
interaction terms when evaluating AKI risk factors or the
effect of AKI on outcome, which could lead to spurious
findings. This was a single-center study, impeding on
generalizability. However, our population was very similar,
in terms of surgical severity scores and in terms of AKI rates
described using various definitions, to populations described
in other studies (Table 4). Although we controlled for various
surrogate illness severity measures, we cannot be completely
sure that this vital factor was adequately controlled for when
evaluating the effect of AKI on outcomes. We could not
evaluate urine output as a marker of AKI or in defining AKI,
as these data were not available from our databases. Previous
research suggests that considering changes in urine output in
addition to SCr to define AKI adds little to the final AKI
designation and to the association between AKI and
outcomes.1,23 Nevertheless, future research should evaluate
the utility of early urine output changes in defining AKI in
this population. We also did not evaluate urine indices of AKI
(such as fractional excretion of sodium), as data were not
available. However, these indices are rarely used in the child
post-operative cardiac population as almost all patients
receive loop diuretics post-operatively, precluding the use of
such markers.
This study supports the need for ongoing research to
identify early AKI biomarkers and to study AKI treatments in
the vulnerable population of children undergoing heart
surgery. The detailed description of disease patterns will be
useful for the design of future biomarker studies and clinical
trials. The use of early small SCr rise as a biomarker and of
selected clinical factors should be incorporated while study-
ing early AKI prediction.
MATERIALS AND METHODS
Design, setting, and participant selection
This was a retrospective study at the Montreal Children’s Hospital,
Canada. Children undergoing open chest surgery between 28
December 2002 and 28 September 2007 were eligible. Patients with
no SCr measured during their intensive care stay were excluded.
Patients were identified from an institutional quality assurance
database (Pediatric Intensive Care Evaluations (PICUEs) 3.2.3).
Institutional ethics approval was received and the need for informed
consent was waived.
Data sources and collection
Data were acquired from our institution’s (1) ‘PICUEs’, (2)
Cardioaccess and (3) clinical laboratory databases.
PICUes database. The PICUEs 3 software is a proprietary
database used to record clinical, diagnostic, and outcome data
prospectively on all pediatric intensive care unit patients since
September 2002. The following variables were extracted: birth date,
gender, hospital, and intensive care unit admission and discharge
dates, intensive care unit admission weight and height, survival
outcome and date of death, lowest systolic blood pressure (mm Hg)
on POD 1, duration (days) of mechanical ventilation, vasopressor
and antibiotic administration and number of days of receiving
extracorporeal support including renal replacement therapy (hemo-
dialysis, continuous renal replacement therapy, peritoneal dialysis).
POD 1 refers to the day of surgical procedure.
Cardioaccess database. The Cardioaccess database is a
proprietary software that links to the Society of Thoracic Surgeons
Congenital database and includes prospectively collected preopera-
tive, operative, and post-operative variables. The following variables
were extracted: primary diagnosis, operative procedure, cardiopul-
monary bypass time, aortic cross-clamp time, and cc/kg blood
(packed red blood cells) administered during surgery.
On the basis of diagnosis and procedure, two surgical severity
scores were calculated: the Aristotle score24 and the Risk Adjustment
in Congenital Heart Surgery (RACHS-1) score.25 The Basic Aristotle
score is the sum of three weighted variables based on surgical
procedure (anticipated morbidity, anticipated mortality, and
surgical difficulty) and is associated with increased mortality.24,26
Each variable has a numeric value from one to five, with a score
range from 3 to 15.24 RACHS-1 was developed by an expert panel, 25
which developed six categories designed to differentiate surgical risk
on the basis of procedure. Increase in the RACHS-1 category is
associated with an increase in mortality.25,27 There is no RACHS-1
classification for heart transplantation or pacemaker insertion,
hence these diagnoses were classified as ‘other’. We also classified
890 Kidney International (2009) 76, 885–892
or ig ina l a r t i c l e M Zappitelli et al.: Acute kidney injury after pediatric heart surgery
patients as having a RACHS-1 score o or X3; patients requiring
pacemaker insertion were classified with a RACHS-1 score o3
and those undergoing heart transplantation were classified with a
score X3.
Hospital laboratory database. We recorded the highest AM
(midnight to noon) and PM (noon to 23:59) serum creatinine (SCr)
for each intensive care admission day, beginning on POD 1. The
higher of these two values was used for daily AKI classification.
Baseline renal function was estimated using preoperative SCr values
(within a week before surgery). If no recent SCr was available, we
utilized the lowest SCr in the previous month (instead of the
previous 3 months,1,11 as a large proportion of our participants were
very young, and also to account for growth-associated SCr rise). If
no baseline estimate was available, it was estimated using minimum
norms for age and gender.4
Description of outcomes
We defined AKI using pRIFLE criteria, which include SCr and urine
output criteria. We did not have urine output available and therefore
only used SCr criteria (pRIFLESCr).
4 We have shown that AKI
defined by these criteria (pRIFLESCr) leads to an identical AKI
distribution as when the more recent adult AKI definition (the
Acute Kidney Injury Network staging) is used.4 pRIFLEScr defines
AKI as ‘Risk (R)’ (mild): SCr rise between 1.5 and o2 times
baseline; ‘Injury’ (I) (moderate): SCr rise between 2 and o3 times
baseline; ‘Failure’ (F) (severe): SCr rise X3 times baseline. The
maximal SCr throughout intensive care unit admission was divided
by the baseline SCr to derive the highest pRIFLESCr attainment. Each
intensive care unit day’s pRIFLESCr status was recorded to calculate
the duration (days) of AKI episodes, to determine when AKI first
occurred and to evaluate progression from pRIFLESCr R (mild) AKI
to more severe forms. We evaluated for ‘repeat AKI episodes’.
Patients with a ‘new’ SCr rise after an initial AKI resolution (no
pRIFLESCr AKI) for 48 h were classified as having a repeat AKI
episode. Because of recent data displaying the potential importance
of smaller SCr rises,10 we performed subset analyses defining AKI as
aX25% SCr rise from baseline (pRIFLESCr25). Other outcomes for
which the presence of AKI was the main predictor were intensive
care and hospital lengths of stay and duration (days) of mechanical
ventilation.
Statistical analysis and data management
Continuous variables were examined for distribution and expressed
as mean±s.d., median (interquartile range or IQR) as appropriate.
Categorical variables were expressed as percentage (%). Univariate
associations between risk factors and AKI were evaluated
using Student’s t-tests or w2-tests. Continuous variables
following non-normal distributions were ln-transformed for use in
parametric tests.
We evaluated multiple potential AKI risk factors (age, gender,
baseline estimated glomerular filtration rate by the Schwartz
formula,28 cardiopulmonary bypass time, cross-clamp time, blood
cc/kg given during surgery, Aristotle or RACHS-1 scores, days
receiving mechanical ventilation, vasopressor or antibiotics and
lowest POD 1 blood pressure) using univariate analyses. We used
multiple logistic regression to evaluate independent AKI risk factors.
We suspected collinearity between variables, hence before entering
variables into the regression model, we evaluated the correlation
matrix of all variables and eliminated variables with a high (r40.8)
correlation and chose a priori which variables to enter into the final
model. Our sample size allowed us to evaluate interaction terms
between age and other remaining variables. We repeated the
logistic regression analysis using the Aristotle score and then using
RACHS-1 staging (o vs X3).
We evaluated the effect of AKI on outcomes. We used
Cox regression (death censored), controlling for potential con-
founders determined a priori, to evaluate the effect of AKI on
intensive care and hospital lengths of stay and ventilation duration.
Results were no different when linear regression was used (not
shown). We evaluated the effect of a 25% SCr rise (pRIFLESCr25) on
longer intensive care/hospital lengths of stay and duration of
ventilation.
In patients who did not have a X50% SCr rise on POD 1, we
evaluated the diagnostic characteristics of 25 to o50% SCr rise on
POD 1, as well as any SCr rise on POD 1 to predict a X50% rise
within 48 h. We evaluated the receiver operating characteristic curve
and calculated the area under the curve, treating percentage rise of
POD 1 SCr from baseline as a continuous variable. We performed
the same analyses for POD 2, including only patients who did not
have aX50% SCr on POD 1 or POD 2. STATA 10 (College Station,
TX, USA) was used for all analyses.
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